Carlyle Group in talks to acquire Baxter's kidney care unit for over $4 billion

From Investing.com: 2024-07-08 09:21:03

Shares of Baxter International surged over 5% as Carlyle Group enters exclusive talks to acquire the company’s kidney care spinoff, Vantive, for over $4 billion. The deal, expected to be announced soon, has been deemed reasonable by Wells Fargo analysts, who project an EPS dilution of 13-15%. Baxter disclosed plans to separate the unit due to supply-chain issues and declining demand for dialysis services.



Read more at Investing.com: Baxter stock pops on reports of Carlyle’s potential buyout of its kidney care unit By Investing.com